InvestorsHub Logo
Followers 9
Posts 235
Boards Moderated 0
Alias Born 03/06/2018

Re: None

Thursday, 08/06/2020 2:18:02 PM

Thursday, August 06, 2020 2:18:02 PM

Post# of 44690
FDA grants inhaled use IND for RLF-100 (aviptadil) to treat patients with moderate and severe COVID-19 aiming to prevent progression to respiratory failure


https://finance.yahoo.com/news/fda-grants-inhaled-ind-rlf-050000708.html?.tsrc=fin-srch

Aviptadil is now shown as the first COVID therapeutic to block replication of the SARS-CoV-2 virus in human lung cells and monocytes, while also preventing synthesis of cytokines in the lung